| [1] |
Moatti-Cohen M, Garrec C, Wolf M, et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura[J]. Blood, 2012, 119(24): 5888-5897.
|
| [2] |
Zhou Z, Nguyen TC, Guchhait P, et al. Von Willebrand Factor, ADAMTS-13, and thrombotic thrombocytopenic purpura[J]. Semin Throm Hemost, 2010, 36(1):71-81.
|
| [3] |
Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII：von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura[J]. N Engl J Med, 1982, 307(23):1432-1435.
|
| [4] |
Kremer Hovinga JA, Lammle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura[J]. Hematology Am Soc Hematol Educ Program, 2012: 610-616.
|
| [5] |
Fujimura Y, Matsumoto M, Isonishi A, et al. Natural history of Upshaw-Schulman syndrome on ADAMTS13 gene analysis in Japan[J]. J Thromb Haemost, 2011, 9(Suppl 1):283-301.
|
| [6] |
Ferrari S, Mudde GC, Rieger M, et al. IgG subclass distribution of anti-ADAMTS13 antiodies in patient with acquired thrombotic thrombocytopenic purpura[J]. J Thromb Haemost, 2009, 7(10):1703-1710.
|
| [7] |
Ferrari S, Scheiflinger F, Rieger M, et al. Prognostic value of anti-ADAMTS13antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity[J]. Blood, 2007, 109(7):2815-2822.
|
| [8] |
Elliott MA, Nichols WL Jr, Plumhoff EA, et al. Posttransplatation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review[J]. Mayo Clin Proc, 2003, 78(4): 421-430.
|
| [9] |
Jacob S, Dunn BL, Qureshi ZP, et al. Ticlopidine-，clopidogrel-，and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)[J]. Semin Thromb Hemost, 2012, 38(8): 845-853.
|
| [10] |
Martin JN Jr, Bailey AP, Rehberg JF，et al. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006[J]. Am J Obstet Gynecol, 2008, 199(2):98-104.
|
| [11] |
George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome[J]. Curr Opin Hematol, 2003, 10(5):339-344.
|
| [12] |
黄亚珍，张跃明，杨伟文，等. 妊娠合并血栓性血小板减少性紫癜的早期诊断和治疗[J]. 中国实用妇科与产科杂志，2010, 26(11):856-858.
|
| [13] |
Martin JN Jr, Bailey AP, Rehberg JF, et al. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006[J]. Am J Obstet Gynecol, 2008, 199(2):98-104.
|
| [14] |
Hunt BJ, Thomas-Dewing RR, Bramham K, et al. Preventing maternal deaths due to acquired thrombotic thrombocytopenic purpura[J]. J Obstet Gynaecol Res, 2013, 39(1):347-350.
|
| [15] |
Scully M, Thomas M, Underwood M, et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes[J]. Blood, 2014, 124(2):211-219.
|
| [16] |
阮长耿，余自强. 血管性血友病与血栓性血小板减少性紫癜. 血液病学：中华医学会血液学分会继续医学教育教材汇编[G].苏州，2012. 江苏：中华医学会血液学分会，2012：154-164.
|
| [17] |
Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies[J]. Br J Haematol, 2012, 158(3):323-335.
|
| [18] |
Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy[J]. Blood, 2013, 121(1):38-47.
|
| [19] |
Ojeda-Uribe M, Afif N, Dahan E. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases[J]. Clin Rheumatol, 2013, 32(5):695-700.
|
| [20] |
王天红，程澄，李映桃. 妊娠合并血栓性血小板减少性紫癜的研究进展[J]．国际妇产科学杂志，2014, 41(1):7-9, 21.
|
| [21] |
张岱，张学玲，金燕志. 妊娠合并血小板减少144例分析[J]. 中国妇幼保健，2006, 21(20):2797-2799.
|
| [22] |
王大鹏，梁梅英，王山米. 妊娠合并极重度血小板减少26例临床分析[J]. 中华妇产科杂志，2010, 45(6):401-405.
|